Videos | Channels | Search |
In this movie, the Vice President, MD, Dm.Sc Torben Mogensen and the Hospital Research Director, MD, PhD Ove Andersen explains why suPAR has been implemented in routine use in the Emergency Department.
01:35 minutes
Tags: copenhagen university, crp, disease, elderly, hvidovre hospital, immune activation, inflammation, prognosis, prognostic, risk, risk recognition, routine biomarker, severe, severity, severity and prognosis., supar is a biomarker of disease presence, triage, virogates